The Use of Soluble Transferrin Receptor in the Detection of rHuEPO Abuse in Sports

McGrowder, Donovan; Brown, Paul; Alexander-Lindo, Ruby Lisa; Budall, Shirley; Irving, Rachael; Gordon, Lorenzo
January 2010
Biochemistry Insights;2010, Issue 3, p7
Academic Journal
Erythropoietin (EPO) increases the number of circulating erythrocytes and muscle oxygenation. The recombinant forms of EPO have indiscriminately been used by athletes, mainly in endurance sports to increase their erythrocytes concentration, thus generating a better delivery of oxygen to the muscle tissue. The administration of recombinant human erythropoietin (rHuEPO) except for therapeutic use was prohibited by the International Olympic Committee (IOC) and its unauthorized use considered as doping. In the last few years, a number of studies using parameters indicative of accelerated erythropoiesis have investigated a number of indirect methods for the detection of rHuEPO abuse. No single indirect marker has been found that can satisfactorily demonstrated rHuEPO misuse. Soluble transferrin receptor (sTfR) is a new marker of iron status and erythropoietic activity. It has been included in multivariable blood testing models for the detection of performance enhancing EPO abuse in sports. Indirect markers of altered erythropoiesis give reliable evidence of current or discontinued rHuEPO usage. This review describes the physical, biological and pharmacokinetic properties of endogenous EPO and its recombinant form. It also discusses the available strategies for the detection of rHuEPO abuse in sports, involving the use of sTfR concentration directly or in mathematical multivariate models.


Related Articles

  • Doping v vzdržljivostnih Å¡portih Eritropoetin (EPO). Smrkolj, Luka // Sport: Revija Za Teoreticna in Prakticna Vprasanja Sporta;2012, Vol. 60 Issue 1/2, p75 

    Erytropoietin (EPO) is an endogenous hormone synthesized in special epithelial cells in renal peritubular capillaries. It is the main factor in human erytropoiesis. EPO is synthesised mostly in kiddneys, some in liver and in brain. Recombinant human erytropoietin (rHuEPO) was at first used only...

  • High Hematocrit Resulting from Administration of Erythropoiesis-stimulating Agents Is Not Fully Predictive of Mortality or Toxicities in Preclinical Species. Andrews, Dina A.; Pyrah, Ian T. G.; Boren, Babette M.; Tannehill-Gregg, Sarah H.; Lightfoot-Dunn, Ruth M. // Toxicologic Pathology;Apr2014, Vol. 42 Issue 3, p510 

    We conducted a retrospective analysis of publicly available preclinical toxicology studies with erythropoiesis-stimulating agents (ESAs) to examine common adverse events in rats, Beagle dogs, and cynomolgus monkeys. Mortality and/or thrombotic events were reported sporadically in a subset of...

  • Anti-EPO and anti-NESP antibodies raised against synthetic peptides that reproduce the minimal amino acid sequence differences between EPO and NESP. De Bolós, C.; Giménez, E.; De Bolóz, C.; Belalcazar, V.; Andreau, D.; Borrás, E.; De La Torre, B. G.; Barbosa, J.; Segura, J.; Pascual, J. A. // Analytical & Bioanalytical Chemistry;Aug2007, Vol. 388 Issue 7, p1531 

    Erythropoietin (EPO) is a hormone that regulates red blood cell production. Recombinant human EPO (rHuEPO) and NESP (novel erythropoiesis stimulating protein) have been produced for therapeutic purposes and also to improve sports performance. The primary sequences of rHuEPO and NESP differ by...

  • Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit. Andrews, Dina A.; Boren, Babette M.; Turk, James R.; Boyce, Rogely W.; He, Yudong D.; Hamadeh, Hisham K.; Mytych, Daniel T.; Barger, Troy E.; Salimi-Moosavi, Hossein; Sloey, Bethlyn; Elliott, Steve; McElroy, Patricia; Sinclair, Angus M.; Shimamoto, Grant; Pyrah, Ian T. G.; Lightfoot-Dunn, Ruth M. // Toxicologic Pathology;Apr2014, Vol. 42 Issue 3, p524 

    We recently reported results that erythropoiesis-stimulating agent (ESA)–related thrombotic toxicities in preclinical species were not solely dependent on a high hematocrit (HCT) but also associated with increased ESA dose level, dose frequency, and dosing duration. In this article, we...

  • Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact. Kiss, Zoltán; Elliott, Steven; Jedynasty, Kinga; Tesar, Vladimír; Szegedi, János // European Journal of Clinical Pharmacology;Apr2010, Vol. 66 Issue 4, p331 

    Cloning of the human erythropoietin ( EPO) gene and development of the first recombinant human erythropoietin (rHuEPO) drug were truly breakthroughs. This allowed a deeper understanding of the structure and pharmacology of rHuEpo, which in turn inspired the discovery and development of...

  • International Olympic Committee moves against `junk' merchandising.  // Hudson Valley Business Journal;11/25/96, Vol. 7 Issue 15, p21 

    Reports on the International Olympic Committee's (IOC) announcement that it will tighten its rules to keep the Olympic Games from being degraded by unchecked commercialization and `junk merchandising.' Accusing Atlanta, Georgia's municipal government of undermining the Summer Games; Efforts to...

  • Less wretched excess, please. Witteman, Paul A. // Time;8/17/1992, Vol. 140 Issue 7, p72 

    Argues that while the Olympics are good for the companies that clothe, feed and otherwise remunerate the athletes, it is also good for the International Olympic Committee, a self-perpetuating oligarchy that is not in the Olympic movement's interest. Eliminating the temptation of bribery by...

  • Do it yourself. Kirshenbaum, Jerry; O'Brien, Richard // Sports Illustrated;2/15/93, Vol. 78 Issue 6, p10 

    Discusses the International Olympic Committee's (IOC) dismissal of a news report that it had hired a public relations firm to promote the IOC for the Nobel Peace Prize. Comments from the IOC.

  • Village people. Kirshenbaum, Jerry; O'Brien, Richard // Sports Illustrated;3/29/93, Vol. 78 Issue 12, p9 

    Reports on efforts by the International Olympic Committee (IOC) to get Olympic athletes to stay in the Olympic Village during competition. Athletes who stayed in five-star hotels during the Barcelona Olympics; Having the IOC officials stay at the Olympic village; More.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics